1. Home
  2. CDTX vs QCRH Comparison

CDTX vs QCRH Comparison

Compare CDTX & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • QCRH
  • Stock Information
  • Founded
  • CDTX 2012
  • QCRH 1993
  • Country
  • CDTX United States
  • QCRH United States
  • Employees
  • CDTX N/A
  • QCRH N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • QCRH Major Banks
  • Sector
  • CDTX Health Care
  • QCRH Finance
  • Exchange
  • CDTX Nasdaq
  • QCRH Nasdaq
  • Market Cap
  • CDTX 1.6B
  • QCRH 1.3B
  • IPO Year
  • CDTX 2015
  • QCRH 1993
  • Fundamental
  • Price
  • CDTX $101.51
  • QCRH $75.28
  • Analyst Decision
  • CDTX Strong Buy
  • QCRH Buy
  • Analyst Count
  • CDTX 11
  • QCRH 3
  • Target Price
  • CDTX $91.60
  • QCRH $88.83
  • AVG Volume (30 Days)
  • CDTX 1.2M
  • QCRH 103.1K
  • Earning Date
  • CDTX 11-06-2025
  • QCRH 10-22-2025
  • Dividend Yield
  • CDTX N/A
  • QCRH 0.32%
  • EPS Growth
  • CDTX N/A
  • QCRH N/A
  • EPS
  • CDTX N/A
  • QCRH 6.63
  • Revenue
  • CDTX N/A
  • QCRH $322,873,000.00
  • Revenue This Year
  • CDTX N/A
  • QCRH N/A
  • Revenue Next Year
  • CDTX N/A
  • QCRH $14.12
  • P/E Ratio
  • CDTX N/A
  • QCRH $11.48
  • Revenue Growth
  • CDTX N/A
  • QCRH N/A
  • 52 Week Low
  • CDTX $10.14
  • QCRH $60.83
  • 52 Week High
  • CDTX $106.63
  • QCRH $96.08
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 73.64
  • QCRH 43.21
  • Support Level
  • CDTX $96.35
  • QCRH $75.06
  • Resistance Level
  • CDTX $106.63
  • QCRH $77.48
  • Average True Range (ATR)
  • CDTX 6.77
  • QCRH 1.61
  • MACD
  • CDTX 1.87
  • QCRH -0.42
  • Stochastic Oscillator
  • CDTX 87.48
  • QCRH 14.74

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.

Share on Social Networks: